We have previously shown that short peptides incorporating the sequence KLVFF can bind to the ϳ40-amino acid residue Alzheimer amyloid ␤-peptide ( 
Accumulating evidence ascribes the deposition of large fibrillar polymers of the Alzheimer amyloid ␤-peptide (A␤) 1 in the brain parenchyma and vasculature (1) (2) (3) as the key step in the pathogenesis of Alzheimer's disease. In support of this contention, specific mutations in the gene encoding the ␤-amyloid precursor protein (4) have been shown to co-segregate with familial forms of Alzheimer's disease (5, 6) . These mutations have phenotypes with either increased production of the A␤-peptide or formation of structural variants of the A␤-peptide (e.g. terminating at amino acid A␤ 42 ) that more easily aggregate and form amyloid fibrils (7) (8) (9) . Mutations in the genes encoding the presenilins that also co-segregate with early onset familial Alzheimer's disease (10 -13) lead to an increased production of A␤ X-42 (14) . Moreover, transgenic mice expressing mutant human A␤ precursor protein develop lesions similar to those found in Alzheimer's disease (15, 16) .
A number of pharmacological strategies aimed at decreasing the production of the A␤-peptide or precluding its tissue deposition have been suggested. These include the use of protease inhibitors to prevent amyloidogenic processing of A␤ precursor protein (17) , altering A␤ precursor protein metabolism by pharmacological manipulation of signal transduction pathways (18) , and inhibition of amyloid fibril formation with small molecules (19 -23) . Inhibition of fibril formation is essential since fibrils of A␤, but not monomeric A␤, are toxic to neurons (21, 24, 25) and protease-resistant (26) , and therefore can accumulate in and probably also damage the tissue.
Previously, it was shown that residues 16 -20 in the A␤-peptide (KLVFF) are important in the A␤-A␤ interaction (19, 27) . The linear hexapeptide Ac-QKLVFF-NH 2 was found to be capable of both binding to the A␤-peptide and preventing its polymerization into fibrils (19) . In the present work we have focused on (i) identifying the structure or structures in the A␤-peptide that bind KLVFF-containing ligands, (ii) using molecular modeling to study the interaction between these ligands and model their binding site, (iii) developing novel peptide ligands based on amino acids in D configuration, and (iv) investigating the effects of these novel metabolically stable ligands on amyloid fibril formation in vitro.
EXPERIMENTAL PROCEDURES
Materials-Synthetic A␤ was obtained from Dr. David B. Teplow, Biopolymer Laboratory at Harvard University. All other soluble peptides were obtained from Research Genetics, Huntsville, AL. Unless otherwise indicated, all reagents were from Sigma. The peptide KKLVFFA (this peptide will be referred to hereafter as LBMP1620) and A␤ were iodinated using the Bolton-Hunter technique. Following the reaction, the iodinated peptide was purified on a Vydac C-4 reverse phase liquid chromatography column (0.21 ϫ 15 cm) using a solvent system containing 0.1% trifluoroacetic acid in water (buffer A) and 0.1% trifluoroacetic acid in acetonitrile (buffer B).
Synthesis of Peptides on Cellulose Membranes-The technique used is essentially identical to the SPOT technique described by Frank (28) . Cellulose membranes (Whatman 1Chr) were derivatized with N,NЈ-diisopropylcarbodiimide-activated Fmoc ␤-alanine. A spacer, consisting of 2 molecules of ␤-alanine, was coupled to derivatized filters. The indicated peptides were then synthesized using Fmoc-protected and pentafluorophenyl-or N,NЈ-diisopropylcarbodiimide-activated amino acids dissolved in N-methylpyrrolidone. Coupling efficiency was monitored by bromphenol blue staining.
Binding Experiments-Following the blocking of filters with 0.05% Tween 20 in Tris-buffered saline (TBS), they were incubated in the presence of 2-20 M 125 I-labeled A␤ or 125 I-labeled LBMP1620 at 20°C for 12 h in TBS, pH 7.4, supplemented with 1% bovine serum albumin. Subsequently, the filters were washed repeatedly in the same buffer containing 0.5 M NaCl and dried. Radioactivity bound to the filters was visualized by autoradiography and quantitated using densitometry.
Molecular Modeling of KLVFF Docking to the Homologous A␤ Sequence-The docking of a KLVFF (A␤ 16 -20 ) pentamer to an A␤ [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] segment was studied using the Insight/Discover 2.9.7 program suite (Biosym/Molecular Simulations, San Diego, CA). The two polypeptides were simulated in a periodic box (47 ϫ 20 ϫ 24 Å) with 607 explicit water molecules and an 8-Å cut-off. Default values were used for all other conventions. The A␤ [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] segment was initialized in a ␤ sheet conformation.
Inhibition of Amyloid Fibril Formation-The ligands were dissolved in hexafluoroisopropyl alcohol and diluted with TBS to a final concentration of 100 M.A ␤was dissolved in hexafluoroisopropyl alcohol before the addition of the freshly prepared ligand solution to a final A␤ concentration of 100 M. The final concentration of hexafluoroisopropyl alcohol was 2%. In another experiment the samples were dissolved directly in TBS. The samples were thereafter incubated at 37°C for 48 h. Subsequently, the peptides were examined by electron microscopy, and inhibition of fibril formation was estimated semiquantitatively.
Electron Microscopy-The peptides were dissolved in TBS (pH 7.4) and incubated at 37°C for 48 h. Polymers were sedimented by centrifugation at 20,000 ϫ g for 20 min, the supernatant was aspirated, and the pellet was resuspended in 100 l of water by a short sonication. Aliquots (8 l) of the resuspended material were placed on grids covered by a carbon-stabilized Formvar film. After 30 s, excess fluid was withdrawn, and the grids were negatively stained with 3% uranyl acetate in water. Finally, the specimens were examined and photographed in a Jeol electron microscope 100CX at 60 kV.
RESULTS

Identification of Sequences in the A␤-peptide Serving as
Binding Sites for KLVFF-containing Ligands-The previously used peptide sequence Ac-QKLVFF-NH 2 has a limited solubility in aqueous buffers. We therefore synthesized a peptide sequence with improved water solubility, LBMP1620.
The 31 possible decamers corresponding to A␤ [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] ,A ␤
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, A␤ [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] ,...,A␤ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] were synthesized on a cellulose membrane with their COOH terminus covalently bound to the membrane as described (28) . The membrane was incubated overnight at 20°C in the presence of 2 M 125 I-LBMP1620. Following repeated washing in TBS, binding of 125 I-LBMP1620 to the immobilized peptides was determined by autoradiography and subsequent densitometry. The radioligand bound to peptides A␤ [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] ,A ␤
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, and A␤ 16 -25 . This binding pattern is similar to the one found when immobilized peptides were incubated with 125 I-A␤ (19) . The decamer A␤ [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] (i.e. HHQKLVFFAE) was selected for further studies. The minimal sequence required for 125 I-LBMP1620 binding was determined by systematic truncation at the NH 2 -and COOH terminus, respectively (Fig. 1) . The results revealed that the LBMP1620-binding site had certain distinct features. (i) Only pentapeptides or larger peptides displayed significant binding, and (ii) binding peptides contained the sequence KLVFF or LVFFA (i.e. A␤ 16 -20 or A␤ [17] [18] [19] [20] [21] ). It is concluded that the A␤-ligand LBMP1620 binds to the A␤-peptide by interacting with a domain with a homologous primary sequence.
A peptide entirely composed of amino acids in D configuration with the sequence klvff (lowercase marks amino acids in D configuration) was synthesized using the SPOT technique and assayed for 125 I-LBMP1620 binding. This peptide failed to bind 125 I-LBMP1620 (data not shown) indicating that the KLVFF-KLVFF interaction is stereospecific.
Immobilized A␤ 16 -20 Shows Decreased Binding to 125 I-A␤ after Incubation with LBMP1620 -KLVFF was synthesized on cellulose membranes. They were then incubated overnight at 20°C with incubation buffer alone, 20 M A␤ (19) , which complicates studies of the structural basis for binding using solution phase techniques (e.g. NMR). The small sizes of the present peptides made them particularly suitable for computer simulations using molecular modeling. Repeated runs of molecular dynamics were followed by conjugate gradient energy minimization. Peptides with the sequences HHQKLVFFAED (A␤ [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] ) and KLVFF (A␤ 16 -20 ) were docked (Fig. 2) . Two common docking motifs were observed roughly corresponding to parallel and anti-parallel ␤-sheet conformations, respectively. The parallel conformation was considerably higher in energy, and hence the anti-parallel conformation was chosen for further studies. terminal Phe of the pentamer typically projected outward. This motif would suggest a prominent role for Lys, Leu, and the COOH-terminal Phe residues in A␤ aggregation as observed in earlier experiments (19) . Over the course of the run, the A␤ segment developed an elbow, with the docked pentamer in the interior. Presumably, during longer simulations this conformational shift could significantly enhance the binding of KLVFF pentamers to A␤.
Identification of A␤-ligands Exclusively Composed of Amino Acids in D Configuration
Using Combinatorial Peptide Chemistry-LBMP1620 contains several proteolytic cleavage sites and is highly sensitive to proteolysis (26) . We therefore decided to design a ligand with the same binding properties as LBMP1620 but that would be resistant to proteolysis. Since proteolytic enzymes are not capable of hydrolyzing peptide bonds between amino acids in D configuration, ligands entirely composed of D-amino acids should be able to withstand enzymatic proteolysis. Here it was shown that the shortest peptide binding efficiently to LBMP1620 was a pentamer (see Fig. 1 ). Therefore, pentapeptides exclusively composed of D-amino acids were synthesized. A combinatorial pentapeptide library, theoretically containing all 2,476,099 permutations of the 19 D-amino acids (cysteine was excluded to avoid unwanted disulfide bonds), was synthesized as described (29) I-LBMP1620 are listed in Fig. 4 . As seen in the figure, f in the second and l in the third position were critical for binding. The f in position 2 could be replaced with y, and l in position 3 could be replaced with m, but not concurrently. In position 1, l and y showed higher binding than w, whereas l was favored in position 4. The fifth residue could be either one of the three amino acids tested. It is unlikely that binding observed in these experiments was the result of nonspecific protein adhesion since the reaction mixture contained relatively large quantities of bovine serum albumin.
Functional Properties of Pentapeptide Ligands Identified in Combinatorial Libraries of All D-Amino Acids-From the 39
125 I-LBMP1620 binding peptides showed in Fig. 4 , yfllr and lflrr were selected for further studies. The reason for selecting these peptides was that they contain one or two D-arginine residues, thus making them more hydrophilic and water-soluble than other binding peptides. We also selected a non-binding peptide with the sequence yyrrl as control. The peptides were incubated with synthetic A␤ at equimolar concentrations (100 M) as described (19) . When A␤ was incubated alone, a dense network of amyloid fibrils with a diameter of about 6 -8 nm and undefined lengths was formed (Fig. 5A) . The addition of the non-binding control peptide yyrrl had no effect on the polymerization of A␤ (Fig. 5B) . On the other hand, lflrr markedly reduced the amount of polymers produced and instead of elongated fibrils short rodlike structures were formed (Fig. 5C ). The putative toxicity of these structures has not been studied. However, it has been shown that it is the fibrillar form, not the amorphous form, of aggregated A␤ that mediates neurotoxicity (21) . A less distinct effect was obtained with yfllr under these conditions, and a mixture of elongated fibrils and diffuse aggregates appeared (Fig. 5D) . When the D-pentapeptides were incubated alone no detectable polymers or aggregates were formed (not shown), in partial contrast to the previously studied KLVFF-containing peptide ligand made up of L-amino acids (19) .
In another set of experiments, a lower concentration of A␤ 1-40 (5 M) was incubated with a 10-fold excess of the Dpentapeptides (50 M). In this case, A␤ 1-40 alone gave rise to fibrils with a similar width but shorter length than described above. Both lflrr and yflrr almost completely blocked the formation of fibrils, whereas yyrrl again had no effect (not shown). No differences between samples predissolved in hexafluoroisopropyl alcohol and samples dissolved directly in TBS were detected. The present method is designed to assay the inhibition of amyloid fibril formation, and hence we cannot exclude the possibility that small, potentially toxic, aggregates are being formed in the presence of ligands. However, preliminary results from fluorescence correlation spectroscopy studies indicate that LBMP1620 dissolves preformed soluble A␤ aggregates completely. 2 
DISCUSSION
Our previous data indicated that the KLVFF (A␤ 16 -20) sequence was critical for A␤ fibril formation. However, it was not clear whether fibril formation involved interaction between homologous sequences or not. Here, we have used LBMP1620 as the labeled probe for screening defined sequences in A␤ , ranging from tripeptides to decapeptides, and thereby identified the sequence that KLVFF-containing ligands bind to within the A␤ 1-40 molecule. The identified binding site docking to KLVFF was then subjected to molecular modeling.
Our next aim was to use the acquired data to search for a protease-stable inhibitor of A␤ fibril formation. Random combinatorial pentapeptide libraries made up from D-amino acids, and consequently protease-stable, were probed with labeled LBMP1620. The three D-amino acids most efficiently promoting binding in each position were selected, and out of these all 243 possible pentapeptides were synthesized and assayed for LBMP1620 binding. Two of the binding peptides and one nonbinding peptide were synthesized on a larger scale, and their capacity of inhibiting A␤ fibril formation in solution was tested.
The first experiments conclusively showed that the KLVFFcontaining ligand binds to the homologous sequence in A␤ (Fig.  1) . The data obtained in binding studies were used in computer simulations of docking between KLVFF and A␤ [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . An antiparallel arrangement was shown in the minimum energy conformation. Residues Lys and Leu in KLVFF interact with the Phe (A␤ 20 ) in the homologous sequence in A␤ [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] , thereby stabilizing the formation of a ␤-sheet structure (Fig. 2) . This is in agreement with previous experimental data showing that the substitution of Lys, Leu, and the COOH-terminal Phe in KLVFF with Ala leads to loss of binding capacity (19) .
Since the first experiment revealed that LBMP1620 binding requires a sequence of at least five amino acids, we chose to use a combinatorial library consisting of pentamers of D-amino acids. By using a short peptide capable of binding to a region critical for polymerization of A␤ (i.e. LBMP1620), the risk of identifying D-pentapeptides binding to non-relevant regions of A␤ (i.e. NH 2 -and COOH-terminal to A␤ 16 -20 ) was minimized. Of the 243 pentapeptides synthesized from the most efficiently binding amino acids (Table I) , 39 were found to bind 125 I-LBMP1620. The composition of these binding peptides indicates that hydrophobic interactions are necessary for binding (Fig. 4) . Although r can be found in position 4 or 5, l is more frequent in these positions. Positions 2 and 3 were most critical for binding, being l and f, respectively, in most of the binding peptides. In position 1, l and f were preferred over w. Some of the binding peptides showed similarities with a reversed KLVFF, e.g. yfllr (Fig. 4) , indicating the formation of a parallel ␤-sheet (KLVFF forming an anti-parallel ␤-sheet according to molecular modeling). However, the positions critical for binding to LBMP1620, 2 (f) and 3 (l), would then correspond to non-critical residues in KLVFF. Molecular modeling of the D-amino acid ligands docking to KLVFF might reveal the nature of this interaction.
An interesting question is how A␤-ligands, such as those described here, affect the physiological and pathological properties of aggregated and non-aggregated A␤-peptide. It is well known that aggregated full-length and truncated variants of the A␤-peptide are toxic to several neuronal and non-neuronal cell types (30) . Moreover, substances capable of inhibiting the polymerization have been shown to prevent A␤-associated toxicity (21) (22) (23) , which points to the fact that the higher order structure is important for the toxicity of these peptides. An A␤-ligand has to meet several important criteria to be a useful inhibitor of fibril formation in vivo. These include acceptable bioavailability, pharmacokinetics allowing passage of the blood-brain barrier, access to the desired site of action, and low . The 243 permutations of the amino acids shown in Table I 
toxicity. The present D-ligands are resistant to proteolysis and should therefore have acceptable bioavailability. Those that were studied functionally were chosen because of their relatively high hydrophilicity. Ligands to be used in vivo should probably be more hydrophobic because this increases the probability that they will pass the blood-brain barrier (31) . Several of the 39 D-ligands presented in Fig. 4 have a high content of hydrophobic residues and hence should have properties allowing them to pass the blood-brain barrier. At present, there is no information regarding the toxicity of these compounds. On balance, several of the D-ligands are potentially useful for testing the hypothesis that A␤-amyloidogenesis in vivo may be inhibited by ligands binding to the KLVFF motif. A fragment of the A␤-peptide corresponding to amino acids 25-35 undergoes polymerization and has neurotoxic properties (30, 32, 33) . In these and our previous studies (19), we have not been able to identify ligands capable of binding efficiently to this region of the peptide. There are several possibilities for this failure. (i) A ligand efficiently binding to this region has to be larger than the penta-to decapeptides tested here and previously (19) ; (ii) the covalent linkage of ligands to a matrix via their COOH termini may prevent the adoption of the conformation necessary for interaction with (i.e. binding to) amino acids 25-35; and (iii) the polymerization of the hydrophobic 25-35 segment is not directly related to the polymerization of full-length A␤-peptide.
The overall conclusion from these studies is that not only the KLVFF peptide (A␤ 16 -20 ) but also structurally different peptides consisting of non-natural amino acids have the capability of binding A␤ and preventing its assembly into amyloid fibrils. Therefore, it is reasonable to assume that pharmacologically useful organic non-peptide molecules with similar functional properties as the present ligands can be synthesized.
